The AVMA is seeking comments from AVMA members, entities, and other veterinary organizations on the FDA’s recent draft guidance regarding compounding.
To help our members and others understand the contents of the FDA’s draft Guidance for the Industry (GFI) 256, “Compounding Animal Drugs from Bulk Substances,” we have created a summary of the guidance. The summary indicates neither approval nor disapproval of the draft’s contents—it is intended to lead you through the draft’s provisions so you might provide your thoughts to the AVMA. The feedback we receive will help shape the AVMA’s response.
The FDA has requested submission of comments by February 18, 2020. Therefore, we encourage you to read through the summary and compoundingavma [dot] org (submit your feedback) to compoundingavma [dot] org by January 17, 2020.
At that time, the AVMA will prepare and submit a collated response to the FDA as we continue our efforts to advocate for access to needed medications on behalf of the profession.
Learn more about the background of this guidance in our previous blog.